Tilmann Lantzsch
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Cancer, Hypoxia, and Metabolism, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)(2014)137 cited
- → Monocyte Chemoattractant Protein-1 Serum Levels in Patients with Breast Cancer(2004)132 cited
- → Lymphatic Mapping of Sentinel Nodes in Early Vulvar Cancer(2002)119 cited
- → Interleukin-1 and Interleukin-6 Gene Polymorphisms and the Risk of Breast Cancer in Caucasian Women(2005)118 cited
- → Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors(2017)102 cited
- → Sentinel node procedure in Ib cervical cancer: a preliminary series(2001)101 cited
- → Sacrospinous ligament fixation for vaginal vault prolapse(2001)90 cited
- → Ezrin Promotes Ovarian Carcinoma Cell Invasion and Its Retained Expression Predicts Poor Prognosis in Ovarian Carcinoma(2006)72 cited
- → Sertoli-Leydig cell tumor(2001)55 cited
- → Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial(2010)49 cited